INTRODUCTION
17β-estradiol is the subject of extensive recent research efforts due to its widespread use for amelioration of postmenopausal symptoms and as a contraceptive. A substantial part of the experimental animal studies have been conducted in ovariectomized (ovx) rats receiving exogenous 17β-estradiol to maintain stable plasma concentrations. Characterization and control of the experimental conditions requires analysis of 17β-estradiol concentrations in rat sera. Due to the very low serum levels, the measurement is frequently performed by competitive radioimmunoassays (RIA).
17β-estradiol circulates in the blood weakly bound to albumin (60%) and strongly bound to sex hormone binding globulin (SHBG) (38%) which leaves only 2-3% in the free, physiologically active fraction [1] . To measure the free fraction only and for minimizing matrix effects, an extraction step is conventionally employed to eliminate the water-soluble carrier molecules from the sample. Most "inhouse" RIAs still employ this technique, commonly using diethyl ether as extraction medium.
However, during the last decade the extraction step has been increasingly excluded from most of the available commercially manufactured RIAs (referred to as "direct" contrary to the "indirect" RIAs including an extraction step). These kits offer a fast and convenient way of measuring 17β-estradiol and are also frequently employed in rat models [2] [3] [4] [5] [6] [7] [8] [9] [10] .
Because of their widespread use, substantial efforts have been made to validate the commercial direct RIAs for use in human samples by comparing with other methods, e.g. enzyme immunoassay (EIA) [11] [12] [13] , chemiluminescent immunoassays (CLIA) [11, 12, 14, 15] and gas chromatography mass spectrometry (GCMS) [16, 17] , and also by investigating the correlation between different RIAs [11, 12, [16] [17] [18] [19] [20] [21] [22] [23] [24] . But because of the obvious risk of inter-species differences in the sample matrix, these studies only offer partial guidance to researchers about to measure 17β-estradiol samples from laboratory animals. Methods for analyzing 17β-estradiol have been assessed for use in sera from the macaque [25] , but -to our knowledge -no previous studies has tested the validity of commercial 17β-estradiol RIA kits in rat sera.
The aim of the current study was to compare the results of three direct 17β-estradiol RIAs from DPC (Siemens Healthcare Diagnostics Inc., formerly Diagnostic Products Corporation), DSL (Diagnostic Systems Labs) and MPB (MP Biomedicals, formerly ICN Biomedicals) and to investigate how the concentrations measured using these kits were affected by the adding of a diethyl ether extraction step.
MATERIAL AND METHODS

Animals
The one hundred and twenty female rats of the Sprague-Dawley strain used in the current study were purchased from B&K Universal (Sollentuna, Sweden). All procedures were conducted in accordance to the National Committee for Animal Research in Sweden and Principles of Laboratory Animal Care (NIH publication no. 86-23, revised 1985). The study was approved by the Local Ethics Committee for Animal Care and Use at Linköping University. The animals used in this experiment were also included in a study of 17β-estradiol administration methods (separate manuscript simultaneously submitted for publication).
Hormone treatment
Seventy-five animals were ovx by the dorsal route, and subsequently administered 17β-estradiol by three different methods (daily injections, silastic capsules and slow-release hormone pellets). The aims of the different administration regimens were to yield physiological levels of 17β-estradiol in the blood. Remaining 45 animals were divided into an ovx control group (n=15) and three native control groups according to cycle phase at time of blood sampling (proestrus: n=10, estrus: n=10 and diestrus: n=9). One of the thirty animals in the native control groups were excluded due to an anatomic anomaly making vaginal smear, and thus monitoring of cycle phase, impossible. This part is thoroughly described in another manuscript simultaneously submitted for publication.
Blood sampling
Blood samples of 1 mL were collected on seven occasions during a 6-week period from the animals in the 17β-estradiol treated groups, and on a single occasion in the control groups. All samples except the last were collected by venipuncture into Serum Tube (Vacuette ® Serum Tubes, Hettich Labinstrument AB, Sollentuna, Sweden) one for each animal. For the last sampling, the animals were sacrificed and trunk blood collected. After clotting, the blood samples were centrifuged at 2500 rpm for 10 minutes. Then the serum was aspired, transferred to another vial and frozen until analysis.
This resulted in a total of 552 serum samples to be analyzed. 2) DSL 125 I radioimmunoassay kit (17β-estradiol double antibody, DSL-4800, Webster, TX, USA).
The reported intra-and inter-assay coefficients of variation are, respectively, 6.5-8.9% and 7.5-12.2%, and the lowest limit of detection 2.2 pg/mL (8.1 pmol/L).
3) MPB
125
I radioimmunoassay kit (17ß-estradiol (E2) Double Antibody -125 I RIA Kit, MP Biomedicals, Solon, OH, USA). The reported intra-and inter-assay coefficients of variation are, respectively, 4.7-10.6% and 5.9-11.9%. Lowest detection limit is not reported by the manufacturer.
All three abovementioned kits have been used for assaying 17β-estradiol levels in rats in several previous studies [3] [4] [5] [6] [7] [8] .
Different kits from the same manufacturer were of the same LOT-number, and before the analysis, the reagents were pooled to avoid inter-assay variation. The three analyses (DPC, DSL and MPB)
were performed in single séances. For each assay three standard curves were analyzed, and all samples were read against to their closest standard curve. The serum volumes used in each tube, both for standard curve and samples, were 100 µL for the DPC and DSL RIAs, and 25 µL for the MPB RIA. Standards and samples were analyzed in duplicate and measured for 300 seconds in a gamma counter (Gamma Master 1277; Wallac-Pharmacia, Turku, Finland).
All 552 unextracted samples were analyzed with the DPC kit, 350 with the DSL kit and 395 with the MPB kit. Due to scarce sample volumes, the samples analyzed with DSL and MPB were not completely the same, but overlapping and with similar concentration ranges.
Sources of error
Due to limited availability of sample material the analyses in this study were performed in half the recommended serum and standard volumes. A concern was that this could affect the result and limit were analyzed for significant differences using ANOVA (Systat version 11, Systat Software, Inc.
San Jose, California).
Excluded test results
The test results of ten samples were excluded due to an unacceptable discrepancy between the duplicates. This was the case for one unextracted sample analyzed with the DPC kit, three extracted and three unextracted samples analyzed with the DSL kit and for three unextracted samples analyzed with the MPB kit.
Another four test results obtained with the unextracted DSL method were excluded from the analysis because of technical problems when performing the assay.
Three samples turned out to have concentrations much higher than the highest concentration of the standard curve in all of the three unextracted analyses. These results ran the risk of unmotivated impact of the statistical analyses and were therefore excluded (large concentration range). proportional but also has a minor non-proportional component. Correlation: r=0.91.
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As is depicted in Fig.1 G- 
Differences in concentrations of 17β-estradiol in native rats
The 17β-estradiol concentrations of the 29 native control rats in this study were measured with all three kits, extracted and unextracted, and the values shown in table 1 were obtained. (Table 1 )
DISCUSSION
Substantial differences were found when measuring rat serum 17β-estradiol concentrations by means of three commercial direct RIAs. However, all three methods properly reflected the basic 17β-estradiol -related biological processes. Furthermore, preceding the measurements with diethyl ether extraction decreased the absolute concentrations measured, but did not improve the concordance between the methods. Of the RIA kits from DPC, DSL and MPB tested, MPB rendered the highest concentrations of 17β-estradiol and DSL the lowest. Using the DPC kit to measure unextracted samples resulted in 17β-estradiol concentrations in the native rats that best resembled concentrations observed in earlier studies where conventional RIAs, including an extraction step, have been used [26] [27] [28] [29] . The differences in concentrations measured by the kits were indeed large enough to complicate comparisons between studies where kits from different companies are used. However, the relatively high degree of correlation (r=0.91-0.95) indicate that the regression line formulae strongly predict concentrations from one method to another.
The three kits were evidently properly calibrated by 17β-estradiol calibrators, and 17β-estradiol obviously has an identical chemical structure in humans and rats. The crucial question therefore concerns the causes of the observed differences between the kits. The most likely explanation is the difference in reaction of the immunochemical reagents in the kits to the rat serum matrix of the samples. The RIA kits were designed for use in human samples and may therefore not be optimal for rat serum samples. Even if matrix effects in human sera are negliable, it could cause a problem in rat sera because of inter-species matrix differences.
Several previous studies employing human samples have compared direct RIAs with one another and with other methods, frequently showing substantial differences [11] [12] [13] [14] [16] [17] [18] [19] [20] [21] [22] [23] [24] . A representative example is a study by Stanczyk in which three commercial direct 17β-estradiol RIAs, from DPC, DSL and Pantex, two indirect RIAs (one commercial and one "in-house"), two CLIAs and three
EIAs were compared in human sera. There was a good concordance between the two indirect RIAs, but substantial differences among the other tested methods when a broad range of concentrations was included. In agreement with the current study, the concentrations obtained with the DPC RIA were higher than those obtained with the DSL RIA [11] . Of course, all studies do not reveal substantial differences between analytical methods for 17β-estradiol. As an example, Tummon reported good correlation, in particular for high concentrations, between a CLIA from Chiron diagnostics and a coat-a-count RIA from DPC in 505 human samples [15] .
Gas chromatography mass spectrometry (GCMS) is the current golden standard for analysis of 17β-estradiol, and would certainly be the best way of testing any other analytical method's performance in rat sera. To our knowledge such study remains to be done. In 2006 a comparison was performed using human samples measured by four direct commercial RIAs, among them exactly the two RIAs from DPC and DSL tested in the current study, three indirect "in house" RIAs and GCMS. The samples were exclusively from postmenopausal women, and thus the levels of 17β-estradiol measured were very low (<25 pg/mL, <91.8 pmol/L). It was shown that the direct RIAs differed more from GCMS than the indirect RIAs did. Of the direct RIAs DPC correlated best (GCMS= 0.91*DPC+2.7 (based on pg/mL), GCMS= 0.91*DPC+9.9 (based on pmol/L), r=0.83) while DSL correlated a bit less (GCMS= 0.60*DSL-2.0 (based on pg/mL), GCMS= 0.60*DSL-7.3 (based on pmol/L), r=0.70) against the GCMS. In this study DSL rendered higher values than DPC, which is consistent with the current study for the low concentrations in question [17] .
Sample extraction
The purpose of extraction of serum samples in this case is to minimize the influence of all other molecules than 17β-estradiol on the final results. This is e.g. achieved by solid phase extraction or by precipitating the proteins using heat, high ionic strength, lowering pH or (as in the current study) by the adding of a highly hydrophobic reagent [30] . When extracting prior to 17β-estradiol analysis the hydrophobic reagent does not only denaturate the proteins, but also captures the measurand.
Rationally, this seems like a good idea especially for analysis in sera from another species where the matrix is a probable confounder, but, as it turned out in our study, it was not. As aforementioned, the adding of a preceding extraction step generally halved the concentrations measured, which for the native rats in this study gave concentrations that do not agree with what has been seen in previous studies where conventional extraction RIAs have been used [26] [27] [28] [29] . This suggests that the commercial RIAs tested in the current study are not suited for pre-analysis extraction, at least not using the method used in the present study. A possible explanation for this could be that when analyzing unextracted samples the antibody competes with the plasma proteins for binding to 17β-estradiol, thus enabling it to interact with more 17β-estradiol compared to the extracted samples.
Extraction precipitates the plasma proteins and leads to net loss of 17β-estradiol from the samples.
An alternative explanation is that the direct RIA kits used have been specifically calibrated for use in the matrix of human samples.
Earlier studies show much variation in results regarding the effect of extraction on RIA's performances. In one study the same DPC RIA as in this study was used for measurement of 17β-estradiol levels in rats, with and without extraction with diethyl ether. A lowering of the obtained values by approximately 20-30% was observed. This comparatively slight decrease is not consistent with the current study, and the explanations for this could possibly be found in differences in the extraction procedure, which regrettably is not explicitly described in the previous study [2] . In another study three direct 17β-estradiol RIAs (none of the ones used in the current study) were tested in human serum samples with and without organic solvent extraction. It was found that for all tested RIAs, higher concentrations were obtained when extracting, which is not coherent with the current study [20] . Contemplating whether or not to employ an extraction step, it is important to realize that adding extraction to the direct RIA procedures adds an extra source of variability. This calls for strong arguments in favor of the extraction for choosing it to be a part of the procedure. A major advantage may be that extracted plasma samples possibly reflect closer the concentrations of biologically active 17β-estradiol. It has been shown that the plasma protein SHBG lowers the 17β-estradiol values measured in human plasma with a direct double antibody RIA from DPC [31] . Another argument in favor of extraction was suggested by Dighe and Sluss for the measurement of low levels of 17β-estradiol, namely that the reconstitution part of the extraction step offers a possibility of concentrating the sample 17β-estradiol to a level where the used assay method has higher validity and precision [32] . Dowsett & Folkerd also argued in favor of extraction by simply suggesting better correlation between an extracted than an unextracted procedure of a commercial RIA (DSL-39100,
not the DSL-4800 tested in the current study) with a reference in-house RIA in twenty human samples. As in the current study the observed differences were substantial, but as mentioned, it was stated that is was the method employing extracted samples that correlated best with the in-house RIA [21] . Other studies have also reported better concordance with reference in-house RIAs when adding an extraction step: Schioler and Thode tested a number of direct RIAs against an in-house RIA in human samples, and two of the direct RIAs (none of the ones used in the current study) were also assessed using diethyl ether extraction (of both samples and standards). It was found that the direct RIAs tested in this study generally overestimated the 17β-estradiol concentration, but that this overestimation decreased when using extraction [22] . Pazol et al. assessed a direct double antibody RIA from DPC (as in the current study) in macaque serum, and with an extraction step in human serum, comparing the results with the results of an in-house RIA. Both the direct RIA in macaque serum and with extraction in human serum underestimated the concentrations compared with the inhouse RIA, but extraction resulted in a more consistent underestimation along the concentration range studied [25] .
To further complicate the issue it has been shown that the effect of extraction differs between samples collected from women taking hormone replacement therapy (HRT) through different administration routes. The concentrations found in the samples from women on oral HRT were substantially decreased by extraction, while concentrations in samples from women using transdermal HRT were not. This is probably a consequence of the oral therapy resulting in higher levels of circulating estrogen bound to carrier molecules [33] .
The question of whether the most true and biologically relevant 17β-estradiol values using the commercial direct RIAs are obtained with or without extraction, either for use in rat or human samples, remains elusive. Comparing a direct RIA's results in extracted and unextracted serum samples with the results obtained from GCMS is probably needed to finally assess the method's suitability for the addition of a preceding extraction step Dissolving samples after extraction
In earlier experiments conducted in our laboratory the same DPC RIA used in the current study was employed [7, 34, 35] . Extraction with diethyl ether was performed and then the samples were reconstituted with a phosphate buffer containing 0.2% bovine serum albumin (BSA) and 0.1% triton X100, i.e. not with kit zero standard as in the current study. A problem was encountered in that our measured 17β-estradiol concentrations, both in native and hormone manipulated animals, were an order of magnitude higher than what has been shown in other studies. In a pre-trial to the current study the cause of this problem was found to be in the reconstitution step of our procedure (unpublished data). It is evident that the phosphate buffer containing BSA inhibits the binding between the antibody and the radioligand, and since only the samples and not the standard curve were extracted and reconstituted, the resulting 17β-estradiol values turned out falsely high. It could not be determined that any single constituent (e.g. BSA or triton X) was the culprit, so the source of error seems to have been the buffer's impact as a whole on the antibodies' binding properties.
CONCLUSION
The commercial direct RIA kits tested in the present study differ substantially in their results when measuring 17β-estradiol concentrations in rat sera. Furthermore, extraction by means of diethyl ether substantially decreases the concentrations measured and dampen the biological effects observed.
When measuring 17β-estradiol in animals subjected to hormone treatment, it is essential that the levels are compared to native control animals in the same study.
